Microbiological quality assessment of oral probiotic-containing pharmaceuticals and health supplements in Ho Chi Minh City
MedPharmRes · 31.03.2026 · 10 (1) · 44-61
DOI: 10.32895/mpr.25.00072 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedPharmRes, online erschienen am 31.03.2026. Verfasst von Quyen Da Do und 2 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Medicine and Pharmacy at Ho Chi Minh City.
Abstract (Originalsprache)
The global probiotic market continues to expand, yet concerns about product quality persist, particularly regarding mismatches between labeled and actual probiotic content. Assessing the microbiological quality of probiotic pharmaceuticals and supplements in Ho Chi Minh City is crucial to reflect market status and guide quality control. Species identity was confirmed by polymerase chain reaction (PCR) and sequencing. Viable counts were measured by the plate count method at baseline and after 3 months. Key probiotic traits were evaluated following Food and Agriculture Organization/World Health Organization (FAO/WHO) guidelines, including tolerance to simulated gastrointestinal conditions, antimicrobial activity against enteric pathogens, and antibiotic susceptibility via broth microdilution. Of 26 products tested, 18 initially matched label claims for viable count. After 3 months of storage, there was a gradual decrease in viable count, especially among those containing Lactobacillus spp. and Saccharomyces spp., which decreased the number of compliant products to 15. Species mislabeling occurred in 7 products (26.9%), including 3 contained fewer species than claimed, 1 had mismatched species identification, and 3 contained additional species that were not listed on the label. Bacillus spp. showed superior survival rate under acidic and bile salt conditions, while Lactobacillus spp. exhibited the strongest antimicrobial activity. Most strains were antibiotic-susceptible, except some Bacillus spp., displaying minor non-susceptibility to clindamycin. Discrepancies between the labeled and actual probiotic content, both in quantity and species, remain a major challenge for ensuring product reliability and rational use.
Förderung
- University of Medicine and Pharmacy at Ho Chi Minh City
Zitieren
APA
Do, Q. D., Tran, Y. T. N., & Le, A. T. (2026). Microbiological quality assessment of oral probiotic-containing pharmaceuticals and health supplements in Ho Chi Minh City. MedPharmRes, 10(1), 44-61. https://doi.org/10.32895/mpr.25.00072
Vancouver
Do QD, Tran YTN, Le AT. Microbiological quality assessment of oral probiotic-containing pharmaceuticals and health supplements in Ho Chi Minh City. MedPharmRes. 2026;10(1):44-61. doi:10.32895/mpr.25.00072
BibTeX
@article{Do2026,
author = {Do, Quyen Da and Tran, Y Thi Nhu and Le, Anh Tuan},
title = {Microbiological quality assessment of oral probiotic-containing pharmaceuticals and health supplements in Ho Chi Minh City},
journal = {MedPharmRes},
year = {2026},
volume = {10},
number = {1},
pages = {44--61},
doi = {10.32895/mpr.25.00072}
}
EUVIMED